A detailed history of Veracity Capital LLC transactions in Novo Nordisk A S stock. As of the latest transaction made, Veracity Capital LLC holds 4,789 shares of NVO stock, worth $424,832. This represents 0.22% of its overall portfolio holdings.

Number of Shares
4,789
Previous 4,148 15.45%
Holding current value
$424,832
Previous $592,000 3.72%
% of portfolio
0.22%
Previous 0.25%

Shares

16 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 18, 2024

BUY
$119.07 - $145.42 $76,323 - $93,214
641 Added 15.45%
4,789 $570,000
Q2 2024

Jul 22, 2024

SELL
$122.71 - $146.91 $222,227 - $266,054
-1,811 Reduced 30.39%
4,148 $592,000
Q1 2024

Apr 19, 2024

SELL
$102.11 - $135.92 $33,492 - $44,581
-328 Reduced 5.22%
5,959 $765,000
Q4 2023

Jan 22, 2024

SELL
$87.78 - $105.45 $9,216 - $11,072
-105 Reduced 1.64%
6,287 $650,000
Q3 2023

Oct 25, 2023

BUY
$90.94 - $199.54 $323,200 - $709,165
3,554 Added 125.23%
6,392 $581,000
Q2 2023

Jul 20, 2023

SELL
$155.98 - $172.65 $8,266 - $9,150
-53 Reduced 1.83%
2,838 $459,000
Q1 2023

Apr 06, 2023

BUY
$132.34 - $159.14 $5,822 - $7,002
44 Added 1.55%
2,891 $460,000
Q4 2022

Jan 17, 2023

SELL
$102.55 - $135.33 $10,767 - $14,209
-105 Reduced 3.56%
2,847 $0
Q3 2022

Oct 17, 2022

SELL
$95.28 - $116.93 $1,333 - $1,637
-14 Reduced 0.47%
2,952 $294,000
Q2 2022

Jul 18, 2022

BUY
$103.24 - $121.81 $71,751 - $84,657
695 Added 30.6%
2,966 $330,000
Q1 2022

Apr 18, 2022

BUY
$93.1 - $112.54 $4,282 - $5,176
46 Added 2.07%
2,271 $252,000
Q4 2021

Jan 31, 2022

SELL
$95.88 - $117.08 $2,780 - $3,395
-29 Reduced 1.29%
2,225 $249,000
Q3 2021

Oct 13, 2021

BUY
$84.42 - $106.62 $190,282 - $240,321
2,254 New
2,254 $216,000
Q2 2020

Jul 13, 2020

SELL
$58.54 - $67.94 $344,390 - $399,691
-5,883 Closed
0 $0
Q1 2020

May 07, 2020

SELL
$49.46 - $64.78 $37,342 - $48,908
-755 Reduced 11.37%
5,883 $354,000
Q4 2019

May 07, 2020

BUY
$49.86 - $58.26 $330,970 - $386,729
6,638 New
6,638 $384,000

Others Institutions Holding NVO

About NOVO NORDISK A S


  • Ticker NVO
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 2,257,289,984
  • Market Cap $200B
  • Description
  • Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...
More about NVO
Track This Portfolio

Track Veracity Capital LLC Portfolio

Follow Veracity Capital LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Veracity Capital LLC, based on Form 13F filings with the SEC.

News

Stay updated on Veracity Capital LLC with notifications on news.